ALRTClinical Trials•globenewswire•
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships
Sentiment:Positive (75)
Summary
- Successfully initiated enrollment in advanced Phase 2 ovarian cancer trial
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 15, 2025 by globenewswire